Sage Journals: Discover world-class research

Retricted access

Research article

First published 1991-7

Classifying improvements to drug marketing and justifications for claims of efficacy

Peter R. Mansfield

International Journal of Risk & Safety in Medicine

Retricted access

Other

First published 2002-10

Is it Possible to Claim Efficacy if One of Two Trials is Significant While the other Just Shows a Trend?

Gerd Rosenkranz

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 1995-1

Supporting Your Claims: Recent Issues in Cardiovascular Drugs

Shaw T. Chen

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2007-03

Reexamining the Claim of Public Authority Efficacy

Carolyn Bourdeaux

Administration & Society

Retricted access

Research article

First published 1988-7

Impact of Unrecognized Dosing Errors on the Cost and Effectiveness of Pharmaceuticals

John Urquhart, Cynthia Chevalley

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2025-10

How a Treatment Claim Without Reciting Safety and Efficacy Requirements May Survive the Disclosure Requirement Challenge: United Therapeutics Corp. v. Liquidia Technologies,Inc.

Ping-Hsun Chen

Biotechnology Law Report

Retricted access

Letter

First published 2025

“Too small to succeed?” Rethinking efficacy claims in a solriamfetol trial for ME/CFS

Zhihao Lei

Journal of Psychopharmacology

Retricted access

Research article

First published 2007-10

On the Efficacy of Programmatic Searching of Medical Claims for the Occurrence of Hospital Admissions for Coronary Artery Disease

James R. Nestor, Janet G. Knecht

Population Health Management

Open access

Letter

First published 2026

Timing of the Baseline Assessment Confounds Efficacy Claims for a Post-surgical Telehealth Mindfulness Intervention After Lumbar Surgery

Audai H. Abudayeh, Iakiv V. Fishchenko, Lyudmila D. Kravchuk

Global Advances in Integrative Medicine and Health

Retricted access

Research article

First published 2010-4

Prometheus v. Mayo : Is 35 U.S.C. § 101 a Viable Defense to Patents Claiming Methods of Optimizing Therapeutic Efficacy?

Frederick H. Rein, Joseph B. Crystal

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Search results